代表性论著、科研获奖、人才称号 |
代表性论著 1.Ma S, Yang T, Gong H, Wang J, Chen K, Huang W, Xie F, Wang H, Zhang L,Wang Y*. Understanding antibiotic prescribing in the inpatient setting: a synthesis of evidence on determinants and interventions. Antimicrob Resist Infect Control. 2026 Mar 7. doi: 10.1186/s13756-026-01726-7. 2.Huang W, Yang T, Ma S, Wang J, Gong H, Wang H, Sun J, Wang N, Zhang L,Wang Y*. Comparative evaluation of multimodal point-of-care tests to differentiate gram-negative from gram-positive infections in critically ill adults: a diagnostic accuracy study. Infection. 2026 Jan 14. doi: 10.1007/s15010-025-02720-8. 3.Wei D, Ma S, Huang W, Yang T, Chen K, Sun B, Li X, Zhang L,Wang Y*.Whether an optimal strategy exists for VTE prevention in critically ill patients: Insights from guidelines and randomized controlled trials. Eur J Intern Med. 2025 Dec:142:106426. 4.Wang H, Ma S, Huang W, Chen K, Xie J, Wang N, Li Y, Yang Q, Yang X,Wang Y*.Impact of Proton Pump Inhibitors on Osimertinib-Induced Cardiotoxicity in NSCLC Patients. Cardiovasc Toxicol. 2025;25(7):1084-1093. 5.Chen K, Wang C, Wei Y, Ma S, Huang W, Dong Y,Wang Y*.Machine learning and population pharmacokinetics: a hybrid approach for optimizing vancomycin therapy in sepsis patients. Microbiol Spectr. 2025 Mar 31:e0049925. 6.Wang H, Chen K, Ma S, Huang W, Xie J, Wang N, Li Y, Yang Q, Yang X,Wang Y*. PPIs effect in EGFR-TKI-associated interstitial lung diseases in patients with non-small cell lung cancer. BMC Cancer. 2025;25(1):263. 7. Liu Y, Dai M, Zhang K, Zhang L, Lin B, Chen K, Wang H, Gu Z, Yu Y,Wang Y*. Risk of Clostridioides difficile infection following different antibiotics: insights from multi-source medical data. Int J Antimicrob Agents. 2024 Jul 31;64(4):107288. 8.Zhang L, Li P,Liu C, Zheng Q,Wang Y*. Low early anti-factor Xa target achievement rate of low molecular weight heparin for treating venous thromboembolism in intensive care unit patients. J Clin Pharmacol. 2023 Jun;63(6):664-671. 9.Xing Y, Qiu Y, Yang L, Yuan Z,Wang Y*.Cost-effectiveness analysis of screening for peripheral artery disease in patients with coronary artery disease in China: A Markov model.Int J Cardiol. 2023 Jan 15;371:420-426. 10.Xie J, Yang Q, Han X, Dong Y, Zhang T, Li Y, Ji M, Liu C, Cai Y,Wang Y*. Pharmacokinetic/Pharmacodynamic Target Attainment of Different Antifungal Agents in De-escalation Treatment in Critically Ill Patients: A Step toward Dose Optimization Using Monte Carlo Simulation. Antimicrob Agents Chemother. 2022 Jun 21;66(6): e0009922. 科研获奖 1.重症感染患者精准药物治疗管理系统及方法，发明专利，ZL 2024 1 1460575.1 2.中华医学会临床药学分会2025年学术会议“高质量论文”第一名（1/5146） 3.第十二届全国治疗药物监测学术年会“高影响力论文” 4.第十三届药源性疾病与安全用药中国论坛“优秀论文”二等奖 人才称号 1.陕西省创新人才攀登工程“青年科技新星” 2.仲英青年学者（唐仲英基金会-西安交通大学） 3.西安交通大学“青年优秀人才” |
